{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:56Z","timestamp":1786981256244,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10815-025-03701-4","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:54:30Z","timestamp":1763175270000},"page":"661-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of gender-affirming testosterone therapy on ovarian function and oocyte quality in transgender men: a literature review"],"prefix":"10.1007","volume":"43","author":[{"given":"Sophie","family":"Frontczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Agopiantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Zver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Berdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Nallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Decaigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Caroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Blagosklonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-6826","authenticated-orcid":false,"given":"Florence","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"3701_CR1","doi-asserted-by":"crossref","unstructured":"Exp\u00f3sito-Campos P, G\u00f3mez-Balaguer M, Hurtado-Murillo F, Morillas-Ari\u00f1o C. Evolution and trends in referrals to a specialist gender identity unit in Spain over 10\u00a0years (2012\u20132021). J Sex Med. 27 f\u00e9vr 2023;20(3):377\u201387.","DOI":"10.1093\/jsxmed\/qdac034"},{"issue":"5","key":"3701_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jsxm.2018.03.083","volume":"15","author":"MK Auer","year":"2018","unstructured":"Auer MK, Fuss J, Nieder TO, Briken P, Biedermann SV, Stalla GK, et al. Desire to have children among transgender people in Germany: a cross-sectional multi-center study. J Sex Med mai. 2018;15(5):757\u201367.","journal-title":"J Sex Med mai"},{"issue":"2","key":"3701_CR3","doi-asserted-by":"publisher","first-page":"hoac008","DOI":"10.1093\/hropen\/hoac008","volume":"2022","author":"E Mattelin","year":"2022","unstructured":"Mattelin E, Strandell A, Bryman I. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013\u20132018. Hum Reprod Open. 2022;2022(2):hoac008.","journal-title":"Hum Reprod Open"},{"issue":"6","key":"3701_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/AOG.0000000000000540","volume":"124","author":"AD Light","year":"2014","unstructured":"Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124(6):1120\u20137 (d\u00e9c).","journal-title":"Obstet Gynecol"},{"issue":"4","key":"3701_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.xfre.2023.10.006","volume":"4","author":"A Ghofranian","year":"2023","unstructured":"Ghofranian A, Estevez SL, Gellman C, Gounko D, Lee JA, Thornton K, et al. Fertility treatment outcomes in transgender men with a history of testosterone therapy. F&S Reports. 2023;4(4):367\u201374 (d\u00e9c).","journal-title":"F&S Reports"},{"issue":"1\u20132","key":"3701_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/26895269.2020.1841058","volume":"22","author":"H Moseson","year":"2021","unstructured":"Moseson H, Fix L, Hastings J, Stoeffler A, Lunn MR, Flentje A, et al. Pregnancy intentions and outcomes among transgender, nonbinary, and gender-expansive people assigned female or intersex at birth in the United States: results from a national, quantitative survey. Int J Transgend Health. 2021;22(1\u20132):30\u201341.","journal-title":"Int J Transgend Health"},{"key":"3701_CR7","doi-asserted-by":"crossref","unstructured":"Kinnear HM, Moravek MB. Reproductive capacity after gender-affirming testosterone therapy. Hum Reprod. 12 ao\u00fbt 2023;dead158.","DOI":"10.1093\/humrep\/dead158"},{"issue":"2","key":"3701_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/humrep\/des385","volume":"28","author":"K Ikeda","year":"2013","unstructured":"Ikeda K, Baba T, Noguchi H, Nagasawa K, Endo T, Kiya T, et al. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod f\u00e9vr. 2013;28(2):453\u201361.","journal-title":"Hum Reprod f\u00e9vr"},{"issue":"1","key":"3701_CR9","first-page":"19","volume":"8","author":"P Greenwald","year":"2022","unstructured":"Greenwald P, Dubois B, Lekovich J, Pang JH, Safer J. Successful in vitro fertilization in a cisgender female carrier using oocytes retrieved from a transgender man maintained on testosterone. AACE Clin Case Rep. 2022;8(1):19\u201321.","journal-title":"AACE Clin Case Rep"},{"issue":"Suppl 1","key":"3701_CR10","first-page":"S1","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-259.","journal-title":"Int J Transgend Health"},{"key":"3701_CR11","doi-asserted-by":"crossref","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 1 Nov 2017;102(11):3869\u2013903.","DOI":"10.1210\/jc.2017-01658"},{"key":"3701_CR12","doi-asserted-by":"crossref","unstructured":"The ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D\u2019Angelo A, Chuva de Sousa Lopes SM, et al. ESHRE guideline: female fertility preservation\u2020. Human Reproduction Open. 3 Oct 2020;2020(4):hoaa052.","DOI":"10.1093\/hropen\/hoaa052"},{"issue":"2","key":"3701_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0015-0282(16)49155-7","volume":"45","author":"H Amirikia","year":"1986","unstructured":"Amirikia H, Savoy-Moore RT, Sundareson AS, Moghissi KS. The effects of long-term androgen treatment on the ovary. Fertil Steril f\u00e9vr. 1986;45(2):202\u20138.","journal-title":"Fertil Steril f\u00e9vr"},{"issue":"1","key":"3701_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jcem-62-1-16","volume":"62","author":"W Futterweit","year":"1986","unstructured":"Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab. 1986;62(1):16\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3701_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/jcem-69-1-151","volume":"69","author":"T Spinder","year":"1989","unstructured":"Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, et al. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab juill. 1989;69(1):151\u20137.","journal-title":"J Clin Endocrinol Metab juill"},{"key":"3701_CR16","doi-asserted-by":"crossref","unstructured":"Pache T d., Chadha S, Gooren L j. g., Hop W c. j., Jaarsma K w., Dommerholt H b. r., et al. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology. 1991;19(5):445\u201152.","DOI":"10.1111\/j.1365-2559.1991.tb00235.x"},{"key":"3701_CR17","doi-asserted-by":"crossref","unstructured":"Grynberg M, Fanchin R, Dubost G, Colau JC, Br\u00e9mont-Weil C, Frydman R, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reproductive BioMedicine Online. 1 avr 2010;20(4):553\u20138.","DOI":"10.1016\/j.rbmo.2009.12.021"},{"issue":"5","key":"3701_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.tjog.2016.03.004","volume":"55","author":"G Loverro","year":"2016","unstructured":"Loverro G, Resta L, Dellino M, Edoardo DN, Cascarano MA, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55(5):686\u201391.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"6","key":"3701_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.rbmo.2017.03.008","volume":"34","author":"C De Roo","year":"2017","unstructured":"De Roo C, Lierman S, Tilleman K, Peynshaert K, Braeckmans K, Caanen M, et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online juin. 2017;34(6):557\u201366.","journal-title":"Reprod Biomed Online juin"},{"issue":"9","key":"3701_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10815-019-01513-x","volume":"36","author":"C De Roo","year":"2019","unstructured":"De Roo C, Tilleman K, Vercruysse C, Declercq H, T\u2019Sjoen G, Weyers S, et al. Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy: a pilot study. J Assist Reprod Genet. 2019;36(9):1837\u201343.","journal-title":"J Assist Reprod Genet"},{"key":"3701_CR21","doi-asserted-by":"crossref","unstructured":"Marschalek J, Pietrowski D, Dekan S, Marschalek ML, Brandstetter M, Ott J. Markers of vitality in ovaries of transmen after long-term androgen treatment: a prospective cohort study. Mol Med. 5 sept 2020;26:83.","DOI":"10.1186\/s10020-020-00214-x"},{"key":"3701_CR22","doi-asserted-by":"crossref","unstructured":"Grimstad FW, Fowler KG, New EP, Ferrando CA, Pollard RR, Chapman G, et al. Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series. The Journal of Sexual Medicine. 1 Sept 2020;17(9):1807\u201318.","DOI":"10.1016\/j.jsxm.2020.05.029"},{"key":"3701_CR23","doi-asserted-by":"crossref","unstructured":"Co\u015fkun ADE, Ko\u00e7 N, Vural F, D\u00f6nmez EE. Ovarian histology of removed ovaries after gender-affirming testosterone therapy. Int J Surg Pathol. 12 July 2023;10668969231185087.","DOI":"10.1177\/10668969231185087"},{"key":"3701_CR24","doi-asserted-by":"crossref","unstructured":"Bailie E, Maidarti M, Jack S, Hawthorn R, Watson N, Telfer E, et al. The ovaries of transgender men indicate effects of high dose testosterone on the primordial and early growing follicle pool. Reprod Fertil. 1 mars 2023;RAF-22\u20130102.","DOI":"10.1530\/RAF-22-0102"},{"issue":"11","key":"3701_CR25","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/0046-8177(94)90037-X","volume":"25","author":"S Chadha","year":"1994","unstructured":"Chadha S, Pache TD, Huikeshoven JM, Brinkmann AO, van der Kwast TH. Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Hum Pathol. Nov 1994;25(11):1198\u2013204.","journal-title":"Hum Pathol"},{"issue":"5","key":"3701_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","volume":"103","author":"MR Caanen","year":"2015","unstructured":"Caanen MR, Soleman RS, Kuijper EAM, Kreukels BPC, De Roo C, Tilleman K, et al. Antim\u00fcllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. Fertil Steril. 2015;103(5):1340\u20135.","journal-title":"Fertil Steril"},{"key":"3701_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13293-016-0067-9","volume":"7","author":"LJW Tack","year":"2016","unstructured":"Tack LJW, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biol Sex Differ. 2016;7:14.","journal-title":"Biol Sex Differ"},{"issue":"2","key":"3701_CR28","doi-asserted-by":"publisher","first-page":"229.e1","DOI":"10.1016\/j.ajog.2020.01.059","volume":"223","author":"RL Taub","year":"2020","unstructured":"Taub RL, Ellis SA, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol ao\u00fbt. 2020;223(2):229.e1-229.e8.","journal-title":"Am J Obstet Gynecol ao\u00fbt"},{"key":"3701_CR29","doi-asserted-by":"crossref","unstructured":"Yaish I, Tordjman K, Amir H, Malinger G, Salemnick Y, Shefer G, et al. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-M\u00fcllerian hormone and antral follicle count under prolonged treatment. Hum Reprod. 18 Sept 2021;36(10):2753\u201360.","DOI":"10.1093\/humrep\/deab169"},{"issue":"4","key":"3701_CR30","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.fertnstert.2021.03.009","volume":"116","author":"S Lierman","year":"2021","unstructured":"Lierman S, Tolpe A, De Croo I, De Gheselle S, Defreyne J, Baetens M, et al. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men. Fertil Steril. 2021;116(4):1068\u201376.","journal-title":"Fertil Steril"},{"key":"3701_CR31","doi-asserted-by":"crossref","unstructured":"Christodoulaki A, He H, Zhou M, Cardona Barber\u00e1n A, De Roo C, Chuva De Sousa Lopes SM, et al. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer. Hum Reprod. 8 avr 2023;dead068.","DOI":"10.1093\/humrep\/dead068"},{"key":"3701_CR32","doi-asserted-by":"crossref","unstructured":"Lierman S, Tilleman K, Braeckmans K, Peynshaert K, Weyers S, T\u2019Sjoen G, et al. Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic\u00a0spindles. J Assist Reprod Genet. 1 Nov 2017;34(11):1449\u201356.","DOI":"10.1007\/s10815-017-0976-5"},{"key":"3701_CR33","doi-asserted-by":"crossref","unstructured":"Gidoni YS, Raziel A, Strassburger D, Kasterstein E, Ben-Ami I, Ron-El R. Can we preserve fertility in a female to male transgender after a long term testosterone treatment- case report. Fertility and Sterility. 1 Sept 2013;100(3, Supplement):S169\u201170.","DOI":"10.1016\/j.fertnstert.2013.07.1469"},{"key":"3701_CR34","doi-asserted-by":"crossref","unstructured":"Leung A, Sakkas D, Pang S, Thornton K, Resetkova N. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertility and Sterility. 1 Nov 2019;112(5):858\u201365.","DOI":"10.1016\/j.fertnstert.2019.07.014"},{"key":"3701_CR35","doi-asserted-by":"crossref","unstructured":"Adeleye AJ, Cedars MI, Smith J, Mok-Lin E. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men. J Assist Reprod Genet. 1 Oct 2019;36(10):2155\u201361.","DOI":"10.1007\/s10815-019-01558-y"},{"issue":"10","key":"3701_CR36","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s10815-020-01902-7","volume":"37","author":"H Amir","year":"2020","unstructured":"Amir H, Yaish I, Samara N, Hasson J, Groutz A, Azem F. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women. J Assist Reprod Genet. 2020;37(10):2463\u201372.","journal-title":"J Assist Reprod Genet"},{"key":"3701_CR37","doi-asserted-by":"crossref","unstructured":"Asseler JD, Knieriem J, Huirne JA, Goddijn M, Verhoeven MO, van\u00a0Mello NM. Outcomes of oocyte vitrification in trans masculine individuals. Reproductive BioMedicine Online. 1 juill 2023;47(1):94\u2013101.","DOI":"10.1016\/j.rbmo.2023.03.007"},{"key":"3701_CR38","doi-asserted-by":"crossref","unstructured":"Albar M, Koziarz A, McMahon E, Chan C, Liu K. Timing of testosterone discontinuation and assisted reproductive technology outcomes in transgender patients: a cohort study. F&S Reports. 1 mars 2023;4(1):55\u201360.","DOI":"10.1016\/j.xfre.2023.01.004"},{"issue":"1","key":"3701_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.xfre.2020.03.003","volume":"1","author":"K Cho","year":"2020","unstructured":"Cho K, Harjee R, Roberts J, Dunne C. Fertility preservation in a transgender man without prolonged discontinuation of testosterone: a case report and literature review. F&S Reports. 2020;1(1):43\u20137.","journal-title":"F&S Reports"},{"key":"3701_CR40","doi-asserted-by":"crossref","unstructured":"Cromack SC, Walter JR, Smith KN, Elvikis J, Bazzetta SE, Goldman KN. Oocyte cryopreservation in transgender and gender-diverse individuals with or without prior testosterone use. Obstet Gynecol. 26 Sept 2024;","DOI":"10.1097\/AOG.0000000000005749"},{"issue":"2","key":"3701_CR41","first-page":"249","volume":"2","author":"J Gale","year":"2021","unstructured":"Gale J, Magee B, Forsyth-Greig A, Visram H, Jackson A. Oocyte cryopreservation in a transgender man on long-term testosterone therapy: a case report. F S Rep juin. 2021;2(2):249\u201351.","journal-title":"F S Rep juin"},{"issue":"2","key":"3701_CR42","first-page":"153","volume":"3","author":"BA Stark","year":"2022","unstructured":"Stark BA, Mok-Lin E. Fertility preservation in transgender men without discontinuation of testosterone. F S Rep juin. 2022;3(2):153\u20136.","journal-title":"F S Rep juin"},{"key":"3701_CR43","doi-asserted-by":"crossref","unstructured":"Moravek MB, Dixon M, Pena SM, Obedin-Maliver J. Management of testosterone around ovarian stimulation in transmasculine patients: challenging common practices to meet patient needs-2 case reports. Hum Reprod. 1 mars 2023;38(3):482\u20138.","DOI":"10.1093\/humrep\/dead003"},{"key":"3701_CR44","doi-asserted-by":"crossref","unstructured":"White J, Jackson A, Druce I, Gale J. Oocyte cryopreservation and reciprocal in\u00a0vitro fertilization in a transgender man on long term testosterone gender-affirming hormone therapy: a case report. F&S Reports. 1 mars 2024;5(1):111\u20133.","DOI":"10.1016\/j.xfre.2023.11.004"},{"issue":"6","key":"3701_CR45","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/JU.0000000000002437","volume":"207","author":"J Ory","year":"2022","unstructured":"Ory J, Nackeeran S, Balaji NC, Hare JM, Ramasamy AR. Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy. J Urol juin. 2022;207(6):1295\u2013301.","journal-title":"J Urol juin"},{"key":"3701_CR46","first-page":"2905539","volume":"2022","author":"A Mart\u00ednez-Varea","year":"2022","unstructured":"Mart\u00ednez-Varea A, Mart\u00ednez-S\u00e1ez C, Tarraz\u00f3-Millet MP, Diago-Almela V. Early fetal growth restriction of both twins in a transgender man. Case Rep Obstet Gynecol. 2022;2022:2905539.","journal-title":"Case Rep Obstet Gynecol"},{"key":"3701_CR47","first-page":"6246867","volume":"2022","author":"A Hassan","year":"2022","unstructured":"Hassan A, Perini J, Khan A, Iyer A. Pregnancy in a transgender male: a case report and review of the literature. Case Rep Endocrinol. 2022;2022:6246867.","journal-title":"Case Rep Endocrinol"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03701-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03701-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03701-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:49:42Z","timestamp":1770886182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03701-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3701"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03701-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}